Bunnage Mark E. bought VRTX
February 17, 2026 · Form 4 insider transaction
Bunnage Mark E. bought 2,584 shares of Vertex Pharmaceuticals Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,584
Price
$0.00
Total value
N/A
InsiderBunnage Mark E.
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 17, 2026
Filing dateFebruary 19, 2026
Shares owned after13,215
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Restricted stock unit award that vests in installments beginning on February 20, 2027.